|
PUT
|
$87,000
|
152
|
Q3 2024
Reduced 41.54%
|
|
|
CALL
|
$58,000
|
2.49K
|
Q3 2024
New holding
|
|
|
CALL
|
$66,000
|
644
|
Q3 2024
New holding
|
|
|
CALL
|
$44,000
|
169
|
Q3 2024
Reduced 77.47%
|
|
|
PUT
|
$24,000
|
300
|
Q3 2024
New holding
|
|
|
PUT
|
$23,000
|
190
|
Q3 2024
New holding
|
|
|
CALL
|
$29,000
|
250
|
Q3 2024
Added 900.0%
|
|
|
PUT
|
$22,000
|
100
|
Q3 2024
Added 33.33%
|
|
|
CALL
|
$18,000
|
1.95K
|
Q3 2024
Added 150.26%
|
|
|
PUT
|
$24,000
|
50
|
Q3 2024
Added 150.0%
|
|
|
PUT
|
$26,000
|
500
|
Q3 2024
New holding
|
|
|
PUT
|
$25,000
|
100
|
Q3 2024
New holding
|
|
|
CALL
|
$20,000
|
1.31K
|
Q3 2024
New holding
|
|
|
PUT
|
$19,000
|
150
|
Q3 2024
New holding
|
|
|
CALL
|
$27,000
|
980
|
Q3 2024
New holding
|
|
|
CALL
|
$26,000
|
615
|
Q3 2024
Added 186.05%
|
|
|
CALL
|
$11,000
|
75
|
Q3 2024
Added 51.92%
|
|
|
PUT
|
$12,000
|
79
|
Q3 2024
Added 51.92%
|
|
|
CALL
|
$23,000
|
100
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
24
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
100
|
Q2 2024
New holding
|
|
|
CALL
|
$0
|
20
|
Q3 2024
New holding
|
|
|
PUT
|
$6,000
|
15
|
Q3 2024
New holding
|
|
|
CALL
|
$1,000
|
50
|
Q3 2024
New holding
|
|
|
CALL
|
$5,000
|
110
|
Q3 2024
New holding
|
|
|
PUT
|
$0
|
45
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
1
|
Q3 2024
New holding
|
|
|
PUT
|
$0
|
15
|
Q3 2024
New holding
|
|
|
PUT
|
$2,000
|
7
|
Q3 2024
New holding
|
|
|
CALL
|
$2,000
|
200
|
Q3 2024
New holding
|
|
|
CALL
|
$1,000
|
32
|
Q3 2024
New holding
|
|
|
PUT
|
$0
|
12
|
Q3 2024
New holding
|
|
|
CALL
|
$2,000
|
35
|
Q3 2024
New holding
|
|
|
CALL
|
$1,000
|
100
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
1
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
1
|
Q1 2024
Reduced 99.92%
|
|
|
CALL
|
$1,000
|
295
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
30
|
Q3 2024
Added 200.0%
|
|
|
CALL
|
$0
|
40
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
1
|
Q2 2024
New holding
|
|
Syros Pharmaceuticals Ord (Nms)
|
PUT
|
$0
|
65
|
Q3 2024
New holding
|
|
|
CALL
|
$1,000
|
170
|
Q3 2024
Reduced 51.43%
|
|
|
CALL
|
$2,000
|
262
|
Q3 2024
New holding
|
|
Syros Pharmaceuticals Ord (Nms)
|
CALL
|
$0
|
10
|
Q3 2024
New holding
|
|
|
CALL
|
$2,000
|
70
|
Q3 2024
Reduced 53.33%
|
|
|
CALL
|
$0
|
4
|
Q1 2024
New holding
|
|
|
PUT
|
$0
|
4
|
Q3 2024
Added 33.33%
|
|
|
CALL
|
$8,000
|
200
|
Q3 2024
Added 100.0%
|
|
Sagimet Biosciences Srs A Ord
|
CALL
|
$0
|
38
|
Q3 2024
Reduced 74.67%
|
|
|
CALL
|
$1,000
|
200
|
Q3 2024
New holding
|
|